Exhibitors Search
RECEPTECH, Inc.

Booth no.
A60
Exhibition | PARTNERING |
---|---|
Country | Korea, South |
Address | 82 Baegot 2-ro, Siheung-si, Gyeonggi-do, Republic of Korea |
Tel (Rep.) | 010-9425-4723 |
Website | http://receptech.com |
Company Introduction
RecepTech Inc.'s core technology is to develop products that can be applied to various fields through the technology to mass-produce and purify various receptors in E. coli system and the technology to manufacture them into nanodisc.
1. Business Goal - Company is the 'First Mover" in the commercialization of receptor technologies in Health Care (innovative disease diagnosis, new drug screening), Safety Care (detection of virus, hazard/malordorant substance in air, water, and food), and Standardization (in information technologies of sensing, storage, transmission, and reproduction of olfactory/taste receptor signals).
2. Core Value - Company keeps sharpening and securing core technologies in order to provide healthy and happy life with the work-ethics of cooperation, commitment, and perseverance.
1. Business Goal - Company is the 'First Mover" in the commercialization of receptor technologies in Health Care (innovative disease diagnosis, new drug screening), Safety Care (detection of virus, hazard/malordorant substance in air, water, and food), and Standardization (in information technologies of sensing, storage, transmission, and reproduction of olfactory/taste receptor signals).
2. Core Value - Company keeps sharpening and securing core technologies in order to provide healthy and happy life with the work-ethics of cooperation, commitment, and perseverance.
Promotional video
Exhibit Item
A Targeted Anticancer Antibody Screening Platform Based on Cancer Cell-specific GPCR (G-protein-coupled receptor) Nanodisc Antigen
Exhibit Item Images
-
Product Name : A Targeted Anticancer Antibody Screening Platform Based on Cancer Cell-specific GPCR (G-protein-coupled receptor) Nanodisc AntigenProducts using this technology are cancer cell-targeting antibody and small molecule screening system using cancer cell-specific (G-protein-coupled receptor) nanodisc antigen. which can accurately and quickly discover various cancer cell-targeting anticancer antibody and small molecule candidates.
Exhibit Description
Products using this technology are cancer cell-targeting antibody and small molecule screening system using cancer cell-specific (G-protein-coupled receptor) nanodisc antigen. which can accurately and quickly discover various cancer cell-targeting anticancer antibody and small molecule candidates.
Co-Exhibitor or
Partner’s Information
Company Name | Country |
---|---|